WaveMan
WaveMan · Company
SLDE · Slide Insurance Holdings, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

SLDE Slide Insurance (SLDE) Insider Trading, Ownership & Congress Trades

Insurance · Fire, marine & casualty insurance · CIK 0001886428
Quote by TradingView
Form 144 · 11
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
28
Codes C/M, not in net · $130.0K priced

What the filings say about SLDE

Insiders, 180 days
-$56.8M net sold
9 sellers · 12% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$4.3M
11 notices

Slide Insurance insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Slide Insurance Holdings, Inc. insiders sold a net $56.8M of stock across 128 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
LARSON MATTHEW PAUL
Chief Risk Officer
SELL
2026-10-23 SECtraded 2026-10-22
11,150
$307.2K
n/a
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Oct 20, 2026.
  • No other insider sold within 30 days.
Insider activity: Chief Risk Officer LARSON MATTHEW PAUL sold about $307.2K of SLDE under a 10b5-1 plan on Oct 22, 2026.
LARSON MATTHEW PAUL
Chief Risk Officer
SELL
2026-10-22 SECtraded 2026-10-20
2,600
$71.6K
+1.9%
Context
  • 19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Sep 14, 2026.
  • No other insider sold within 30 days.
Insider activity: Chief Risk Officer LARSON MATTHEW PAUL sold about $71.6K of SLDE under a 10b5-1 plan on Oct 20, 2026.
Omiridis Anastasios
Chief Financial Officer
SELL
2026-09-16 SECtraded 2026-09-14
330
$8.7K
+16.3%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 4, 2026.
  • 4 other insiders sold within 30 days.
Insider activity: Chief Financial Officer Omiridis Anastasios sold about $8.7K of SLDE on Sep 14, 2026; 4 other insiders sold within 30 days.
LARSON MATTHEW PAUL
Chief Risk Officer
SELL
2026-09-16 SECtraded 2026-09-14
11,374
$295.7K
+16.3%
Context
  • 18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Sep 3, 2026.
  • 4 other insiders sold within 30 days.
Insider activity: Chief Risk Officer LARSON MATTHEW PAUL sold about $295.7K of SLDE under a 10b5-1 plan on Sep 14, 2026; 4 other insiders sold within 30 days.
ROHDE STEPHEN L
Director
SELL
2026-09-16 SECtraded 2026-09-14
7,500
$198.0K
+16.3%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Aug 14, 2026.
  • 4 other insiders sold within 30 days.
Insider activity: Director ROHDE STEPHEN L sold about $198.0K of SLDE on Sep 14, 2026; 4 other insiders sold within 30 days.
128 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 123 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$56.8M over 180 days
-$6.8M over 90 days · -$42.4M of it by a 10%+ holder
below 90% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+36.5% year over year
more than 84% of Insurance
Margin
38.4% net margin
more than 89% of Insurance
Buybacks
$190.9M repurchased, FY to 2026-06-30
more than 54% of Insurance
Short interest
12.9% of the float short (float per yahoo 2026-10-27) · 5.9 days to cover · settled 2026-10-15
more than 90% of Insurance
What changed in the last 30 days
Oct 23Chief Risk Officer LARSON MATTHEW PAUL sold $378.8K under a 10b5-1 plan (2 trades, Oct 20 to Oct 22)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 22Officer MATTHEW LARSON filed to sell $302.3K by Oct 22 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 20Officer MATTHEW LARSON filed to sell $70.5K by Oct 20 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch SLDE

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+87.6%12M
-1%+29%+58%+88%2025-102025-122026-022026-042026-062026-082026-10 2026-05-18 · Lucas Bruce sold $8.7M2026-05-19 · Lucas Bruce sold $5.2M2026-05-15 · Lucas Bruce sold $5.1M2026-04-09 · Lucas Bruce sold $5.0M2026-04-13 · Lucas Bruce sold $4.7M2026-03-06 · Lucas Bruce sold $4.5M2026-03-31 · Lucas Bruce sold $4.5M2026-05-27 · Lucas Bruce sold $4.3M2026-03-16 · Lucas Bruce sold $4.1M2026-04-29 · Lucas Bruce sold $3.7M2026-05-20 · Lucas Bruce sold $3.5M2026-04-14 · Lucas Bruce sold $3.4M2026-03-05 · Lucas Bruce sold $3.3M2026-06-10 · Lucas Bruce sold $3.3M2026-05-07 · Lucas Bruce sold $3.3M2026-03-26 · Lucas Bruce sold $3.2M2026-04-28 · Lucas Bruce sold $2.9M2026-09-08 · Gries Robert JR sold $2.6M2026-04-27 · Lucas Bruce sold $2.6M2026-04-06 · Lucas Bruce sold $2.5M2026-03-30 · Lucas Bruce sold $2.4M2026-04-20 · Lucas Bruce sold $2.3M2026-04-08 · Lucas Bruce sold $2.2M2026-03-09 · Lucas Bruce sold $2.2M2026-03-10 · Lucas Bruce sold $2.1M2026-04-07 · Lucas Bruce sold $2.1M2026-03-17 · Lucas Bruce sold $1.8M2026-07-06 · Gries Robert JR sold $1.7M2026-05-11 · Lucas Bruce sold $1.7M2026-05-01 · Lucas Bruce sold $1.6M2026-09-09 · Gries Robert JR sold $1.5M2026-05-04 · Lucas Bruce sold $1.3M2026-03-24 · Lucas Bruce sold $1.1M2026-04-29 · LARSON MATTHEW PAUL sold $895.9K2026-05-18 · Lucas Shannon sold $857.7K2026-06-11 · Lucas Bruce sold $761.3K2026-07-07 · Gries Robert JR sold $593.6K2026-08-04 · Gries Robert JR sold $576.7K2026-08-03 · Gries Robert JR sold $573.5K2026-06-24 · Wright Andrew Pardo sold $558.3K2026-05-06 · Gries Robert JR sold $527.6K2026-05-05 · Gries Robert JR sold $523.3K2026-10-22 · MATTHEW LARSON filed to sell $302.3K2026-10-20 · MATTHEW LARSON filed to sell $70.5K2026-09-14 · MATTHEW LARSON filed to sell $282.5K2026-09-14 · STEPHEN ROHDE filed to sell $198.0K2026-09-09 · GRM FAMILY LIMITED PARTNERSHIP filed to sell $1.5M2026-09-08 · GRM FAMILY LIMITED PARTNERSHIP filed to sell $1.2M2026-09-03 · MATTHEW LARSON filed to sell $275.0K2026-09-03 · CHARLES POWELL JR. filed to sell $50.3K2026-08-14 · STEPHEN ROHDE filed to sell $109.5K2026-08-06 · STEPHEN ROHDE filed to sell $105.0K2026-07-31 · STEPHEN ROHDE filed to sell $100.0K2026-07-06 · GRM FAMILY LIMITED PARTNERSHIP filed to sell $13.6M2026-06-24 · Wright Andrew Pardo filed to sell $1.1M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns SLDE: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in SLDE

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

SLDE planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
MATTHEW LARSON
Filed 2026-10-22
$302.3K
MATTHEW LARSON
Filed 2026-10-20
$70.5K
MATTHEW LARSON
Filed 2026-09-14
$282.5K
STEPHEN ROHDE
Filed 2026-09-14
$198.0K
GRM FAMILY LIMITED PARTNERSHIP
Filed 2026-09-09
$1.5M
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $56.8M sold by insiders over 180 days, $4.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

SLDE financials

Revenue growth
+36.5%
XBRL, annual
Net margin
38.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.4B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+40.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$1.0B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.02x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
34.91x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
+53.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+17.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
7.06x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$2.2B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
FCF yield
+30.5%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
0.07x
P/E over trailing EPS growth of 99%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-12
Revenue$1.2B$846.8M
Net income$444.0M$201.1M
EPS (diluted)3.361.66
Operating cash flow$797.4M$553.9M
Cash$1.2B$493.4M
Long-term debt$33.7M$39.2M
Buybacks$40.0M$0
SEC XBRL, fiscal years, as known on 2026-10-28

SLDE Stock Sonar score 5/7 axes

Find similar shapesCompare

SLDE ranks highest on profitability (98th percentile) and financial health (94th), and lowest on risk and compliance (3rd), among Insurance peers.

ProfitHealthGrowthInsidersRisk
Profitability
98
Inputs
  • Return on equity+53.9% · 98 pct, sector of 116
  • Return on assets+17.3% · 98 pct, sector of 122
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Financial health
94
Inputs
  • Debt to equity0.02x · 90 pct, sector of 104
  • Cash flow to debt34.91x · 98 pct, sector of 97
Growth
84
Inputs
  • Revenue growth, YoY+36.5% · 84 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
5
Inputs
  • Net Form 4 buying (codes P and S), 180d-$51.6M · 10 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Risk and compliance
3
Inputs
  • Short interest, % of float+12.9% · 3 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Institutional and government, US patents
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

SLDE filings, in plain words

Are Slide Insurance insiders buying or selling SLDE?

In the 180 days to 2026-10-28, Slide Insurance insiders were net sellers, a net $56.8M across purchases and sales reported on Form 4, by 9 sellers.

Are there planned insider sales of SLDE?

Yes. 11 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $4.3M of stock; the latest, by MATTHEW LARSON, was filed 2026-10-22.

Read the full summary

In the 180 days to 2026-10-28, Slide Insurance insiders were net sellers of SLDE, a net $56.8M across purchases and sales reported on Form 4 by 9 sellers. Most of that figure, $42.4M, came from a holder of 10% or more rather than an officer or director. 12% of the 58 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 11 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $4.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies